Intellectual Property

NIPD Genetics LTD has filed a patent application with the United States Patent and Trademark Office covering the identification of fetal-specific methylation markers on chromosomes 13, 18, 21, X and Y and the development of a Non-Invasive Prenatal Diagnostic (NIPD) test for Down syndrome (trisomy 21). This phase of the patent process has been completed and the second phase, which entails filing the patent at the national level in countries of interest, is in progress in the United States, European Union, Australia, Brazil, Canada, China, India, Israel, Japan, New Zealand, Singapore, South Africa, South Korea and Eurasia as well as the EP extension states Bosnia and Herzegovina and Montenegro.



Share this page

Copyright © 2015 NIPD Genetics LTD. All Rights Reserved

Developed By: Dynamic Works | Powered By: EasyConsole CMS